UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy

Clinical cancer research, 2005-10, Vol.11 (19), p.7087s-7092s

2005

Link zum Volltext

Verfügbarkeit prüfen

Application of High Amplitude Alternating Magnetic Fields for Heat Induction of Nanoparticles Localized in Cancer

Clinical cancer research, 2005-10, Vol.11 (19), p.7093s-7103s

2005

Link zum Volltext

Verfügbarkeit prüfen

Concepts, Consequences, and Implications of Theranosis

Seminars in nuclear medicine, 2012-05, Vol.42 (3), p.147-150

2012

Link zum Volltext

Verfügbarkeit prüfen

Dynamic Force Spectroscopy of Parallel Individual Mucin1-Antibody Bonds

Proceedings of the National Academy of Sciences - PNAS, 2005-11, Vol.102 (46), p.16638-16643

2005

Link zum Volltext

Verfügbarkeit prüfen

Cilengitide targeting of αvβ3 integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts

Cancer research (Chicago, Ill.), 2002-08, Vol.62 (15), p.4263-4272

2002

Link zum Volltext

Verfügbarkeit prüfen

Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloaddition

Chemical communications (Cambridge, England), 2007-01 (7), p.695-697

2007

Link zum Volltext

Verfügbarkeit prüfen

Targeted radionuclide therapy for solid tumors: An overview

International journal of radiation oncology, biology, physics, 2006-10, Vol.66 (2), p.S89-S95

2006

Link zum Volltext

Verfügbarkeit prüfen

Rationales, evidence, and design considerations for fractionated radioimmunotherapy

Cancer, 2002-02, Vol.94 (4), p.1332-1348

2002

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunodetection and therapy of breast cancer

Seminars in nuclear medicine, 2005-04, Vol.35 (2), p.143-151

DeNardo, Sally J.

2005

Link zum Volltext

Verfügbarkeit prüfen

Monospecific bivalent scFv-SH: Effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility

Journal of immunological methods, 2006-03, Vol.310 (1), p.100-116

2006

Link zum Volltext

Verfügbarkeit prüfen

Selective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia

Clinical cancer research, 2007-09, Vol.13 (18), p.5621s-5628s

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Site-Specific ScFv PEGylation for Tumor-Targeting Pharmaceuticals

Bioconjugate chemistry, 2005-01, Vol.16 (1), p.113-121

2005

Link zum Volltext

Verfügbarkeit prüfen

Development of multivalent radioimmunonanoparticles for cancer imaging and therapy

Cancer biotherapy & radiopharmaceuticals, 2008-02, Vol.23 (1), p.82

2008

Link zum Volltext

Verfügbarkeit prüfen

Production of Soluble ScFvs with C-Terminal-Free Thiol for Site-Specific Conjugation or Stable Dimeric ScFvs on Demand

Bioconjugate chemistry, 2004-01, Vol.15 (1), p.16-26

2004

Link zum Volltext

Verfügbarkeit prüfen

In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma

PloS one, 2012, Vol.7 (4), p.e34404

2012

Link zum Volltext

Verfügbarkeit prüfen

A general chemical synthesis platform for crosslinking multivalent single chain variable fragments

Organic & biomolecular chemistry, 2012-02, Vol.1 (8), p.1521-1526

2012

Link zum Volltext

Verfügbarkeit prüfen

Dose Intensified Molecular Targeted Radiotherapy for Cancer—Lymphoma as a Paradigm

Seminars in nuclear medicine, 2010-03, Vol.40 (2), p.136-144

2010

Link zum Volltext

Verfügbarkeit prüfen

Cure of incurable lymphoma

International journal of radiation oncology, biology, physics, 2006-10, Vol.66 (2), p.S46-S56

2006

Link zum Volltext

Verfügbarkeit prüfen

Combined molecular targeting for cancer therapy: a new paradigm in need of molecular imaging

The Journal of nuclear medicine (1978), 2006-01, Vol.47 (1), p.4-5

DeNardo, Sally J

2006

Link zum Volltext

Verfügbarkeit prüfen

Rationales, evidence, and design considerations for fractionated radioimmunotherapy

Cancer, 2002-02, Vol.94 (S4), p.1332-1348

2002

Link zum Volltext

Verfügbarkeit prüfen

Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies

Cancer Immunology, Immunotherapy, 2006-12, Vol.55 (12), p.1451-1458

2006

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer

Clinical cancer research, 2005-10, Vol.11 (19), p.7187s-7194s

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma

The Journal of nuclear medicine (1978), 2007-08, Vol.48 (8), p.1338-1347

2007

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma

International journal of oncology, 2007-10, Vol.31 (4), p.729-740

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(239)
Mit Volltextzugriff
(227)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(158)
Science & Technology
(146)
Life Sciences & Biomedicine
(140)
Radioimmunotherapy
(92)
Biological And Medical Sciences
(85)
Animals
(83)
Medical Sciences
(78)
Female
(76)
Oncology
(76)
Mice
(73)
Radiology, Nuclear Medicine & Medical Imaging
(72)
Antibodies, Monoclonal - Therapeutic Use
(55)
Pharmacology. Drug Treatments
(40)
Male
(39)
Antineoplastic Agents
(32)
Mice, Nude
(32)
Middle Aged
(32)
Radiotherapy Dosage
(29)
Tumors
(29)
Adult
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy

Application of High Amplitude Alternating Magnetic Fields for Heat Induction of Nanoparticles Localized in Cancer

Concepts, Consequences, and Implications of Theranosis

Dynamic Force Spectroscopy of Parallel Individual Mucin1-Antibody Bonds

Cilengitide targeting of αvβ3 integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts

Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloaddition

Targeted radionuclide therapy for solid tumors: An overview

High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody

Rationales, evidence, and design considerations for fractionated radioimmunotherapy

Radioimmunodetection and therapy of breast cancer

Monospecific bivalent scFv-SH: Effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility

Selective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia

Characterization of Site-Specific ScFv PEGylation for Tumor-Targeting Pharmaceuticals

Development of multivalent radioimmunonanoparticles for cancer imaging and therapy

Production of Soluble ScFvs with C-Terminal-Free Thiol for Site-Specific Conjugation or Stable Dimeric ScFvs on Demand

In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma

A general chemical synthesis platform for crosslinking multivalent single chain variable fragments

Dose Intensified Molecular Targeted Radiotherapy for Cancer—Lymphoma as a Paradigm

Cure of incurable lymphoma

Combined molecular targeting for cancer therapy: a new paradigm in need of molecular imaging

Rationales, evidence, and design considerations for fractionated radioimmunotherapy

Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies

Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer

Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma

Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma

Suchergebnisse filtern